Cargando…

Criterion for trismus in head and neck cancer patients: a verification study

PURPOSE: Several cut-off points for trismus in head and neck cancer patients have been used. A mouth opening of 35 mm or less is most frequently used as cut-off point. Due to the variation in cut-off points, prevalence, risk factors and treatment outcomes of trismus cannot be studied in a uniform ma...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Geer, Sarah J., van Rijn, Phillip V., Kamstra, Jolanda I., Roodenburg, Jan L. N., Dijkstra, Pieter U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373229/
https://www.ncbi.nlm.nih.gov/pubmed/30109487
http://dx.doi.org/10.1007/s00520-018-4402-z
_version_ 1783394938991411200
author van der Geer, Sarah J.
van Rijn, Phillip V.
Kamstra, Jolanda I.
Roodenburg, Jan L. N.
Dijkstra, Pieter U.
author_facet van der Geer, Sarah J.
van Rijn, Phillip V.
Kamstra, Jolanda I.
Roodenburg, Jan L. N.
Dijkstra, Pieter U.
author_sort van der Geer, Sarah J.
collection PubMed
description PURPOSE: Several cut-off points for trismus in head and neck cancer patients have been used. A mouth opening of 35 mm or less is most frequently used as cut-off point. Due to the variation in cut-off points, prevalence, risk factors and treatment outcomes of trismus cannot be studied in a uniform manner. To provide uniformity, we aimed to verify the cut-off point of 35 mm or less. Additionally, we aimed to determine associated covariates with reported difficulties when opening the mouth. METHODS: In a cross-sectional design, we measured the mouth opening in 671 head and neck cancer patients at the Department of Oral and Maxillofacial Surgery, at the University Medical Center Groningen. The cut-off point was determined using the receiver operating characteristic curve and Youden index, with reported difficulties when opening the mouth as criterion for trismus. Cut-off points for significant covariates were also determined. RESULTS: The Youden index was highest at 35 mm, with a sensitivity of 0.71 and a specificity of 0.86. Of the covariates analysed, type of treatment modality was significantly associated with reported difficulties when opening the mouth. The highest Youden index for patients treated with surgery alone was 37 mm and for patients treated with radiotherapy alone 33 mm. CONCLUSIONS: The cut-off point of 35 mm or less for trismus was confirmed in a head and neck cancer population and is recommended to be used in future studies. Patients receiving different treatment modalities experience difficulty when opening the mouth differently.
format Online
Article
Text
id pubmed-6373229
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63732292019-03-01 Criterion for trismus in head and neck cancer patients: a verification study van der Geer, Sarah J. van Rijn, Phillip V. Kamstra, Jolanda I. Roodenburg, Jan L. N. Dijkstra, Pieter U. Support Care Cancer Original Article PURPOSE: Several cut-off points for trismus in head and neck cancer patients have been used. A mouth opening of 35 mm or less is most frequently used as cut-off point. Due to the variation in cut-off points, prevalence, risk factors and treatment outcomes of trismus cannot be studied in a uniform manner. To provide uniformity, we aimed to verify the cut-off point of 35 mm or less. Additionally, we aimed to determine associated covariates with reported difficulties when opening the mouth. METHODS: In a cross-sectional design, we measured the mouth opening in 671 head and neck cancer patients at the Department of Oral and Maxillofacial Surgery, at the University Medical Center Groningen. The cut-off point was determined using the receiver operating characteristic curve and Youden index, with reported difficulties when opening the mouth as criterion for trismus. Cut-off points for significant covariates were also determined. RESULTS: The Youden index was highest at 35 mm, with a sensitivity of 0.71 and a specificity of 0.86. Of the covariates analysed, type of treatment modality was significantly associated with reported difficulties when opening the mouth. The highest Youden index for patients treated with surgery alone was 37 mm and for patients treated with radiotherapy alone 33 mm. CONCLUSIONS: The cut-off point of 35 mm or less for trismus was confirmed in a head and neck cancer population and is recommended to be used in future studies. Patients receiving different treatment modalities experience difficulty when opening the mouth differently. Springer Berlin Heidelberg 2018-08-14 2019 /pmc/articles/PMC6373229/ /pubmed/30109487 http://dx.doi.org/10.1007/s00520-018-4402-z Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
van der Geer, Sarah J.
van Rijn, Phillip V.
Kamstra, Jolanda I.
Roodenburg, Jan L. N.
Dijkstra, Pieter U.
Criterion for trismus in head and neck cancer patients: a verification study
title Criterion for trismus in head and neck cancer patients: a verification study
title_full Criterion for trismus in head and neck cancer patients: a verification study
title_fullStr Criterion for trismus in head and neck cancer patients: a verification study
title_full_unstemmed Criterion for trismus in head and neck cancer patients: a verification study
title_short Criterion for trismus in head and neck cancer patients: a verification study
title_sort criterion for trismus in head and neck cancer patients: a verification study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373229/
https://www.ncbi.nlm.nih.gov/pubmed/30109487
http://dx.doi.org/10.1007/s00520-018-4402-z
work_keys_str_mv AT vandergeersarahj criterionfortrismusinheadandneckcancerpatientsaverificationstudy
AT vanrijnphillipv criterionfortrismusinheadandneckcancerpatientsaverificationstudy
AT kamstrajolandai criterionfortrismusinheadandneckcancerpatientsaverificationstudy
AT roodenburgjanln criterionfortrismusinheadandneckcancerpatientsaverificationstudy
AT dijkstrapieteru criterionfortrismusinheadandneckcancerpatientsaverificationstudy